The Chinese Solar Machine Layer by Layer Fire in the Library The Mystery Behind Anesthesia
Julius Axelrod's research helped launch the multibillion-dollar antidepressant market.
Julius Axelrod, a pharmacologist and neuroscientist who shared the 1970 Nobel Prize in medicine for his insights into how human brain cells communicate with each other, died last December 29 at the age of 92. Axelrod's findings about the behavior of neurotransmitters -- the chemical messengers of the brain -- drew a clear connection between the physiology of the brain and emotional moods. His discoveries paved the way for the multibillion-dollar antidepressant drug industry, and in so doing helped give rise to what was later called by some "Prozac Nation."
Axelrod, who was known as "Julie," focused on how the neurotransmitters secreted by a brain cell travel across a synapse (the space between nerves) and are then picked up by a receptor on the surface of another cell. Before Axelrod's research in the late 1950s, scientists believed that neurotransmitters were broken down by enzymes in the brain after they crossed a synapse. But Axelrod's findings suggested that, instead, they were retrieved by the very cells that released them, in a process called "reuptake."
To read the entire article you must log in:
Most of our content — all daily news, blogs, and videos — is free. Magazine stories are paid. To read this story, you must have a subscription or you must use a reading credit. Registration to Technology Review is free and entitles registrants to three free reading credits.
Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.
Our list of the 50 most innovative companies, including the following: